An Emeryville company attempting to tap an Australian weed for a treatment of a precancerous skin condition has landed a new top management team and a $24 million investment after a failed IPO.
Peplin Inc — based in Australia until last year when South San Francisco venture capital firm MPM Capital invested in it— said the [...]
Filed under: News Wire | Tagged: Emeryville biotech, MGM Capital, Peplin | Leave a Comment »
